Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H16O4 |
Molecular Weight | 308.3279 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)C[C@@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
InChI
InChIKey=PJVWKTKQMONHTI-HNNXBMFYSA-N
InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3/t15-/m0/s1
Molecular Formula | C19H16O4 |
Molecular Weight | 308.3279 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:00:20 UTC 2023
by
admin
on
Sat Dec 16 08:00:20 UTC 2023
|
Record UNII |
HP31W7FNP4
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C263
Created by
admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB14055
Created by
admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
|
PRIMARY | |||
|
C148031
Created by
admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
|
PRIMARY | NCIT | ||
|
87738
Created by
admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
|
PRIMARY | |||
|
226-907-3
Created by
admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
|
PRIMARY | |||
|
DTXSID50873382
Created by
admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
|
PRIMARY | |||
|
5543-57-7
Created by
admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
|
PRIMARY | |||
|
54688261
Created by
admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
|
PRIMARY | |||
|
HP31W7FNP4
Created by
admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
with hepatic microsomal preparations from 33 individuals
revealed that the mean ra tes of formation of metabolites of S-warfarin decreased i n the order
7-0H >> 6-0H = 4-0H = dehycl rowarfarin > 8-0H = 10-0H (Kaminsky ct al. , 1984)
IN-VITRO
MODERATE
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE LESS ACTIVE -> PARENT | |||
|
METABOLITE LESS ACTIVE -> PARENT |